市場調査レポート
商品コード
1123233
高血圧症治療薬およびデバイスの世界市場:2022-2028年Global High BP/Hypertension Drugs and Device Market Forecast 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
高血圧症治療薬およびデバイスの世界市場:2022-2028年 |
出版日: 2022年07月30日
発行: Orion Market Research
ページ情報: 英文 105 Pages
納期: 2~3営業日
|
世界の高血圧症治療薬およびモニタリングデバイスの市場規模は予測期間中に5.8%のCAGRで大きく成長すると予測されています。
慢性疾患の有病率の増加や世界の老年人口の増加が同市場の成長を推進しています。また、ジャンクフードの消費による肥満やアルコールの消費量の増加も市場の成長を促す要因の一つとなっています。さらに、医療支出の増加や技術の進歩も市場の成長を後押ししています。
当レポートでは、世界の高血圧症治療薬およびモニタリングデバイスの市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。
Global High Blood Pressure/Hypertension Drugs and Monitoring Device Market Size, Share & Trends Analysis Report by Drugs (Pulmonary Hypertension Drugs and Systemic Hypertension Drugs), by Monitoring Devices (Aneroid Sphygmomanometers, Mercury Sphygmomanometer, Digital Devices, and Ambulatory BP Monitors), By End-User (Hospitals and Clinics and Homecare) and Forecast Period 2021-2027
The global high blood pressure/hypertension drugs and monitoring device market is growing at a considerable CAGR of 5.8% during the forecast period (2021-2027). Hypertension is one of the major causes of fatalities across the globe and occurs due to resistance in the blood flow caused by narrowed arteries. The major factors that are augmenting the growth of the market include the increasing prevalence of chronic diseases and the rising geriatric population across the globe. Aging is associated with a high risk of two events including physiological decline and disease state. The geriatric population in developing economies such as Indonesia, Bangladesh, and Thailand is higher than that in the developed countries. As per a report published by United Nations in 2018, the global population in the age group of 60 years and above is projected to increase from 901 million in 2018 to 1.4 billion by 2030. Moreover, there is a positive correlation between elderly individuals and an increase in the incidence of cardiovascular issues such as hypertension. As per the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7), hypertension occurs in more than two-thirds of individuals in the age group of 65 years and above. An increase in the elderly population constantly increases the burden on healthcare systems globally due to the high prevalence of hypertension and other associated disorders, which could accelerate the growth of the market.
Furthermore, obesity due to consumption of junk food along with rising consumption of alcohol is some of the other factors stimulating the growth of the market. However, certain factors that are affecting the growth of the market include lack of awareness in developing economies, inadequate healthcare infrastructure in underdeveloped countries and the declining average selling price for retailers and manufacturers could hinder the growth of the market during the forecast period. Conversely, the global targets set to reduce the prevalence of hypertension could be perceived as an opportunity for the market players. In addition, increasing healthcare expenditures and technological advancements are also fueling the market growth.
Segmental Outlook
The global high blood pressure/hypertension drugs and monitoring device market is segmented based on drugs, monitoring devices, and end-user. By drugs, the market is segmented into pulmonary hypertension drugs and systemic hypertension drugs. Based on the monitoring devices segment, the market is segmented into aneroid sphygmomanometers, mercury sphygmomanometer, digital devices, and ambulatory BP monitors. Based on the end-user segment, the market is bifurcated into hospitals and clinics, and home care.
Global High Blood Pressure/Hypertension Drugs and Monitoring Device Market Share by Monitoring Devices, 2020 (%)
Global High Blood Pressure/Hypertension Drugs and Monitoring Device Market Share by Monitoring Devices
The aneroid sphygmomanometers segment holds a major market share in 2020. The segment growth is driven by innovations in aneroid technologies and the affordability of aneroid monitors. The apparatus is compact and convenient to use for patients at home. However, aneroid sphygmomanometers have been seen to be less accurate when compared to mercury sphygmomanometers, which could restrain the growth of the segment. The aneroid sphygmomanometers kits providers include Omron Healthcare, Inc., American Diagnostic Corp., Rossmax International Ltd., Hill-Rom Holdings, Inc., and Withings.
Regional Outlooks
The global high blood pressure/hypertension drugs and monitoring device market is analyzed based on the geographical regions that are contributing significantly towards the growth of the market. Based on geography, the market is evaluated into North America, Europe, Asia-Pacific, and the Rest of the World. North America is estimated to be the leading region in the market. Developed healthcare infrastructure and the rising geriatric population are the major factors driving the growth of the market in North America. While Asia-Pacific is estimated to be the fastest-growing region during the forecast period. Large population base along with increasing chronic diseases, rise in awareness among people, and increasing investments by manufacturers are some of the factors that are estimated to fuel the market growth in the Asia-Pacific. According to the reports of the European Society of Cardiology, in 2018, one in every five young adults in India reported high blood pressure. The rising number of undiagnosed cases of high blood pressure will result in an increased need for blood pressure monitoring devices, which will benefit the market growth.
Global High Blood Pressure/Hypertension Drugs and Monitoring Device Market Growth, by Region 2021-2027
Global High Blood Pressure/Hypertension Drugs and Monitoring Device Market Growth, by Region
Market Players Outlook
Key players of the high blood pressure/hypertension drugs and monitoring device market are Hill-Rom Holdings, Inc., American Diagnostic Corporation, Boehringer Ingelheim International GmbH, Bayer AG, Koninklijke Philips N.V., GE Healthcare, Smiths Group plc, Omron Healthcare, Inc., among more. To survive in the market, these players adopt different marketing strategies such as mergers and acquisitions, product launches, geographical expansion, among more. For instance, in February 2021, Hill-Rom Holdings, Inc., announced the acquisition of contact-free continuous monitoring technology from EarlySense. The acquisition reportedly amounted to $30 million intended to expand Hillrom's acute care settings business.
The Report Covers
Market value data analysis of 2020 and forecast to 2027.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global high blood pressure/hypertension drugs and monitoring device market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market entry and market expansion strategies.
Competitive strategies by identifying 'who-stands-where in the market.